8-KOther EventsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Corporate Update (May 27, 2016)

Filed May 27, 2016For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) announced on May 27, 2016, a significant strategic move through the execution of an Agreement and Plan of Merger to acquire FEI Company. This transaction, structured as an all-cash deal, is expected to enhance Thermo Fisher's capabilities and market position. The filing also references supplemental information provided to analysts and investors regarding the proposed acquisition. Investors should note that this 8-K filing primarily serves as a notification of the merger agreement and the availability of related disclosures. Further details regarding the transaction, including the definitive proxy statement from FEI Company, will be filed with the SEC and should be reviewed for comprehensive information about the deal's terms, conditions, and potential implications. The company is leveraging this acquisition to expand its offerings and drive future growth.

Key Highlights

  • 1Thermo Fisher Scientific Inc. (TMO) has entered into an Agreement and Plan of Merger to acquire FEI Company.
  • 2The acquisition is an all-cash transaction.
  • 3The filing is primarily an announcement of the merger agreement, dated May 27, 2016.
  • 4Supplemental information and an investor presentation related to the transaction were made available on the same date.
  • 5FEI Company will file proxy materials with the SEC for its stockholders' review and vote.
  • 6Investors are urged to review all SEC filings related to this transaction for important information.
  • 7The filing indicates that both Thermo Fisher and FEI management may be considered participants in the solicitation of proxies.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce that Thermo Fisher Scientific Inc. has entered into an Agreement and Plan of Merger to acquire FEI Company in an all-cash transaction.

This 8-K filing does not provide specific financial terms like the acquisition price, but it signals a strategic expansion for Thermo Fisher. Investors should refer to the joint press release (Exhibit 99.1) and the investor presentation (Exhibit 99.2) for more details on the rationale and expected benefits, and future SEC filings for detailed financial implications.

This filing announces the execution of the merger agreement and does not specify an expected closing date. The completion of the transaction is subject to the satisfaction or waiver of specified conditions, and further details will be available in subsequent filings.

More detailed information can be found in the joint press release and the investor presentation, both attached as exhibits to this 8-K filing (Exhibit 99.1 and Exhibit 99.2, respectively). Additionally, FEI Company is expected to file proxy materials with the SEC, which will contain important information for FEI stockholders and investors.